

A $2 billion+ pharmaceutical company completed the last and largest in a string of acquisitions meant to redefine the firm for the future. Their challenge was integrating this newly acquired business to capitalize on cross-business growth opportunities.
A key requirement to executing on their strategy was to ensure that key executives from the acquired company were fully engaged in leading the integration and shaping the vision for the combined entity.
ZRG helped the client launch a Performance Leadership initiative to address six of the merger’s top growth and efficiency opportunities, which were chosen by a Steering Committee comprised of senior executives of both organizations. Cross-company project teams used the Performance Leadership framework to drive collaboration, discipline, shared leadership, and speed.
The teams worked for 100 days, each guided by a pair of executive sponsors and a ZRG consultant. The program concluded with each team presenting its proposals and clear implementation plans to the Steering Committee, which made real-time, public yes/no decisions on each recommendation.
The Steering Committee used the initiative to engage, motivate and retain key people from the acquired company by involving them in key decisions related to the merger. The program also gave the Steering Committee an opportunity to assess the strengths and weakness of the people involved in the integration, which led to the creation of growth plans for key participants.
And the participants quickly learned each other’s business, developed trust and formed working relationships that accelerated the integration.
We are in the markets that matter, but we show up like we’re part of your team. Hands-on, high-touch, and built around your goals.